akhatri

MHRA Class 2 Medicines Recall: Ramipril 10mg capsules (Crescent Pharma Limited) Drug alert number: EL(26)A/19 Date issued: 20 April 2026 Crescent Pharma Limited is recalling one batch of Ramipril 10mg Capsules as a precautionary measure due to a potential error at the manufacturing site. DMRC reference number: DMRC-39191133 Company name: Crescent Pharma Limited Medicine Details Ramipril [...]

The post MHRA Class 2 Medicines Recall: Ramipril 10mg capsules (Crescent Pharma Limited) appeared first on Community Pharmacy England.

Some pharmacy owners have flagged that they are experiencing problems submitting their monthly payment claim on the Manage Your Service (MYS) portal. Community Pharmacy England quickly raised this with the NHS Business Services Authority (NHSBSA), who informed us that the issue relates solely to printing batch documentation, the Account Identifier Document. Whilst a copy of [...]

The post MYS batch documentation printing issue appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Rabies, Human normal Immunoglobulin 500IU solution for Injection (Bio Products Laboratory Limited) Drug alert number: EL(26)A/18 Date issued: 30 March 2026 Bio Products Laboratory Limited is recalling one batch of Human Rabies Immunoglobulin following a stability failure for this batch. The batch has shown a reduction in potency of the [...]

The post MHRA Class 2 Medicines Recall: Rabies, Human normal Immunoglobulin 500IU solution for Injection (Bio Products Laboratory Limited) appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 April 2026. Generic drug name (dm+d descriptor) Brand and/or manufacturer Pack Size Special container Afatinib 20mg tablets Giotrif® 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet        [...]

The post 13 products re-classified as special containers from April 2026 appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Dropodex 0.1% w/v Eye Drops, solution (Rayner Pharmaceuticals Limited) Drug alert number: EL(26)A/10 Date issued: 24 February 2026 Rayner Pharmaceuticals limited have informed the MHRA that the batches listed in this notification do not include the concentration of phosphates in the product information. DMRC reference number: DMRC-38371734 Marketing Authorisation Holder: Rayner [...]

The post MHRA Class 4 Medicines Defect Notification: Dropodex 0.1% w/v Eye Drops, solution (Rayner Pharmaceuticals Limited) appeared first on Community Pharmacy England.